Neutrophil gelatinase-associated lipocalin in diagnosis of kidney diseases
- Authors: Eraliev A.R1, Demeubaeva D.M1, Naushabaeva A.E1, Kabulbaev K.A1, Chingaeva G.N1, Abeouva B.A1, Dosym S.M1, Kanatbaeva A.B1
-
Affiliations:
- Issue: No 4 (2013)
- Pages: 57-61
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/261904
- ID: 261904
Cite item
Abstract
Full Text
About the authors
A. R Eraliev
D. M Demeubaeva
A. E Naushabaeva
Email: assiyaandsuccess@gmail.com
K. A Kabulbaev
G. N Chingaeva
B. A Abeouva
S. M Dosym
A. B Kanatbaeva
References
- Davarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008; 241: 89—94.
- Kjeldsen L., Johnsen A.H., Senglöv H. et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993; 268: 10425-10432.
- Вельков В.В. NGAL — «ренальный тропонин»: ранний маркер острого повреждения почек. Научно-практический журнал «Клиниколабораторный консилиум» 2011; 2(38): 90—100.
- Schmidt-Ott K.M., Mori K., Li J.Y. et al. Dual Action of Neutrophil Gelatinase — Associated Lipocalin. J Am Soc Nephrol. 2007; 18: 407—413.
- Shrestha K., Borowski A.G., Troughton R.W. et al. Association between systemic Neutrophil Gelatinase-Associated Lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure. Congest Heart Fail. 2012; 18: 239—244.
- Matthaeus T., Schulze-Lohoff E., Ichimura T. et al. Co-regulation of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 in the post ischemic rat kidney. Clin J Am Soc Nephrol. 2001; 12: 787A.
- Thrailkill K.M., Moreau C.S., Cockrell G.E. et al. Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine. 2010; 37(2): 336—343.
- Liangos O., Wald R., O’Bell J.W. et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: A national survey. Clin J Am Soc Nephrol. 2006; 1: 43—51.
- Wagener G., Jan M., Kim M. et al. Association between increases in urinary neutrophil gelatinase—associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105: 485—491.
- De Mendonca A., Vincent J.L., Suter P.M. et al. Acute renal failure in the ICU: Risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000; 26: 915—921.
- Bennett M.R., Dent C.L. et al. Urinary NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin. J. Am. Soc. Nephrol. 2008; 3(3): 665—673.
- Koyner J.L., Bennett M.R., Worcester E.M. et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008; 74(8): 1059-1069.
- Волгина Г.В. Контраст-индуцированная нефропатия: патогенез, факторы риска, стратегия профилактики (Часть I). Нефрология и диализ 2006; 8(1): 69—77.
- Bachorzewska-Gajewska H., Malyszko J., Sitniewska E. et al. Could neutrophil gelatinase—associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values. Kidney Blood Press Res. 2007; 30: 408-415.
- Hirsch R., Dent C., Pfriem H. et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007; 22: 2089-2095.
- Wasilewska A., Zoch-Zwierz W., Taranta-Janusz K. et al. Neutrophil gelatinase—associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity. Pediatr Nephrol. 2010, 25: 889—897.
- Trachtman H., Christen E., Cnaan A. et al. Urinary neutrophil gelatinase— associated lipocalin in D+HUS: a novel marker of renal injury. Pediatr Nephrol. 2006; 21: 989—994.
- Yilmaz A., Sevketoglu E., Gedikbasi A. et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol. 2009; 24: 2387—2392.
- Bennet M. NGAL distinguishes steroid sensitivity in idiopathic nephritic syndrome. Pediatr Nephrol. 2012; 27: 807—812.
- Doaa M.Y., Amal S.E. Neutrophil gelatinase—associated lipocalin (NGAL) and kidney injury in children with focal segmental glomerulosclerosis. Iranian J Kidney Dis. 2012; 6: 355—360.
- Bolignano D., Lacquaniti A., Coppolino G. et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease. Clin J Am Soc Nephrol. 2009; 4: 337—344.
- Nishida M., Kawakatsu H., Okumura Y. et al. Serum and urinary NGAL levels in children with chronic renal diseases. Pediat Int. 2010; 52(4): 563—568.
- Damman K., van Veldhuisen D.J., Navis G. et al. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail. 2008; 10(10): 997—1000.
- Ding H., He Y., Li K. et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007; 123: 227—234.
- Makris K., Markou N., Evodia E. et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med. 2009; 47(1): 79—82.
- Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Эпидемиологические исследования сердечной недостаточности: состояние вопроса. Cons medicum. 2002; 3: 112—114.
- Damman K., van Veldhuisen D.J., Navis G. et al. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail. 2008; 10(10): 997—1000.
- Choi K.M., Lee J.S., Kim E.J. et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol. 2008; 158(2): 203—207.
- Alvelos M., Pimentel R., Pinho E. et al. Neutrophil Gelatinase-Associated Lipocalin in the Diagnosis of Type 1 Cardio-Renal Syndrome in the General Ward. Clin J Am Soc Nephrol. 2011; 6: 476—481.
- Yndestad A., Landrø L., Ueland T. et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J. 2009; 30(10): 1229—1236.
- Шилов Е.М. Нефрология: Учебное пособие для послевузовского образования. М.: ГЭОТАР-Медиа 2007.
- Шестакова М.В. Современное понятие «хроническая болезнь почек»: методы диагностики, клиническое значение. Сахарный диабет. 2 008; 2: 4—7.
- Лебедева Н.О., Викулова О.К. Маркеры доклинической диагностики диабетической нефропатии у пациентов с сахарным диабетом 1 типа. Сахарный диабет. 2012; 2: 38—45.
- Yang Y.H., He X.J., Chen S.R. et al. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine. 2009; 36(1): 45—51.
- Bolignano D., Lacquaniti A., Coppolino G. et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res. 2009; 32(2): 91—98.
- Nauta F.L., Boertien W.E., Bakker S.J. et al. Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes. Diabetes Care. 2011; 34: 975—981.
- Parikh C.R., Dahl N.K., Chapman A.B. et al. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney International. 2012; 81: 784—790.
- Bolignano D., Coppolino G., Campo S. et al. Neutrophil Gelatinase-Associated Lipocalin in Patients with Autosomal-Dominant Polycystic Kidney Disease. Am J Nephrol. 2007; 27: 373—378.
- Rubinstein T., Pitashny M., Levine B. et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology. 2010; 49: 960—971.
- Suzuki M., Wiers K.M., Klein-Gitelman M.S. et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008; 23(3): 403—412.
- Fagundes C., Pépin M.-N., Guevara M. et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol. 2012; 57(2): 267—273.